Angegliederte Institute, verbundene wissenschaftliche Einrichtungen: Suche
Anzeige der Dokumente 1-1 von 1
Use of Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease Risk in Mild Cognitive Impairment and Subjective Cognitive Decline in Routine Clinical Care in Germany
(2020)
Background: The National Institute of Aging and Alzheimer's Association's diagnostic recommendations for preclinical Alzheimer's disease (AD) and mild cognitive impairment (MCI) define AD by pathological ...
